The Journal For Immunotherapy Of Cancer is reputed journal publishes research related to Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1). The ISSN of the journal is .
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | Journal for ImmunoTherapy of Cancer |
|---|---|
| Publisher | BMJ Publishing Group |
| Publication Country | United Kingdom |
| ISSN | 20511426 |
| Publication Area | Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics |
| Publication Language | ENG |
| Review Process | Anonymous peer review |
| Scopus Indexed | Yes |
The Impact Factor of Journal For Immunotherapy Of Cancer in 2026 is 11.7.
The Journal For Immunotherapy Of Cancer is ranked in Q1.
The Journal For Immunotherapy Of Cancer is indexed in: DOAJ, Web of Science.
There is a fee to publish in the Journal For Immunotherapy Of Cancer. The publication fee is 2390 GBP.
The journal also offers a fee waiver policy.
The Journal For Immunotherapy Of Cancer takes an average of 24 weeks to publish research papers.
The official website of the journal is https://jitc.bmj.com.
Please visit only official website of the journal to submit research papers.